Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb)
نویسندگان
چکیده
منابع مشابه
Extracorporeal immunoadsorption treatment for rheumatoid arthritis.
Immunoadsorption treatment is a non-drug therapy for rheumatoid arthritis. The treatment is based on filtering the patient's plasma through a column containing staphylococcal protein A. The treatment is effective in alleviating the symptoms of severe rheumatoid arthritis in some patients. Data on long-term outcomes are not available. The mechanism of action of this treatment is unclear. Most ad...
متن کاملExtracorporeal IgE Immunoadsorption in Allergic Asthma: Safety and Efficacy
BACKGROUND Prevention of IgE-binding to cellular IgE-receptors by anti-IgE (Omalizumab) is clinically effective in allergic asthma, but limited by IgE threshold-levels. To overcome this limitation, we developed a single-use IgE immunoadsorber column (IgEnio). IgEnio is based on a recombinant, IgE-specific antibody fragment and can be used for the specific extracorporeal desorption of IgE. OBJ...
متن کاملEffect of Extracorporeal Shockwave Therapy Versus Stretching in the Treatment of Athletes With Chronic Plantar Fasciitis
Purpose: Extracorporeal shockwave therapy (ESWT) is a relatively new method in the treatment of musculoskeletal disorders such as plantar fasciitis. This study aimed to compare two methods of treatment with extracorporeal shockwave and stretching in athletes with chronic plantar fasciitis. Methods: The study was a randomized clinical trial. A total of 30 male athletes with chronic plantar fasc...
متن کاملmodern surgical techniques in treatment of patients with cleft lip & cleft palate
چکیده ندارد.
15 صفحه اولRituximab for Treatment of Hemophilia A with High-Responder Inhibitors
Background: The development of inhibitors is a complication factor replacement therapy in hereditary factor VIII deficiency. Several management options are available for the treatment of inhibitor. Rituximab, a monoclonal antibody against CD20, reduces inhibitor level in rare bleeding disorders. The aim of this study was to evaluate the effectiveness of rituximab in lowering or eliminating the ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Haematology
سال: 2001
ISSN: 0007-1048
DOI: 10.1046/j.1365-2141.2001.02510.x